Drug    DrugBank | All Description Patterns💬 Info on mouse-over

No.	Drug (Description in trials)	DrugBank	KEGG DRUG	KEGG GENES	KEGG PATHWAY On map, Yellow: Drug target genes	Disease ID
1	Act-385781a (actelion epoprostenol)	Epoprostenol	[2] D00106, D01337 💬	[1] PTGIR 💬	[3] Neuroactive ligand-receptor interaction, Platelet activation, Vascular smooth muscle contraction	[1] 86 💬
2	Current marketed flolan (epoprostenol sodium)	Epoprostenol	[2] D00106, D01337 💬	[1] PTGIR 💬	[3] Neuroactive ligand-receptor interaction, Platelet activation, Vascular smooth muscle contraction	[1] 86 💬
3	Epoprostenol	Epoprostenol	[2] D00106, D01337 💬	[1] PTGIR 💬	[3] Neuroactive ligand-receptor interaction, Platelet activation, Vascular smooth muscle contraction	[1] 86 💬
4	Epoprostenol for injection	Epoprostenol	[2] D00106, D01337 💬	[1] PTGIR 💬	[3] Neuroactive ligand-receptor interaction, Platelet activation, Vascular smooth muscle contraction	[1] 86 💬
5	Epoprostenol sodico	Epoprostenol	[2] D00106, D01337 💬	[1] PTGIR 💬	[3] Neuroactive ligand-receptor interaction, Platelet activation, Vascular smooth muscle contraction	[1] 86 💬
6	Epoprostenol sodium	Epoprostenol	[2] D00106, D01337 💬	[1] PTGIR 💬	[3] Neuroactive ligand-receptor interaction, Platelet activation, Vascular smooth muscle contraction	[1] 86 💬
7	Epoprostenol-actelion	Epoprostenol	[2] D00106, D01337 💬	[1] PTGIR 💬	[3] Neuroactive ligand-receptor interaction, Platelet activation, Vascular smooth muscle contraction	[1] 86 💬
8	Flolan	-	-	-	-	[1] 86 💬
9	Flolan injection with currently marketed diluent	-	-	-	-	[1] 86 💬
10	Flolan injection with reformulated diluent	-	-	-	-	[1] 86 💬
11	Flolan tm and glycine diluent	Glycine	[1] D00011 💬	-	-	[1] 86 💬
12	Flolan®	-	-	-	-	[1] 86 💬
13	Flolan™ and glycine diluent	Glycine	[1] D00011 💬	-	-	[1] 86 💬
14	New thermo stable formulation of epoprostenol sodium	Epoprostenol	[2] D00106, D01337 💬	[1] PTGIR 💬	[3] Neuroactive ligand-receptor interaction, Platelet activation, Vascular smooth muscle contraction	[1] 86 💬